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Background: To examine histopathologic features and clinical outcomes of intradiverticular bladder carcinomas.
Methods: Twenty-two consecutive patients with intradiverticular bladder carcinoma treated with either endoscopic
transurethral resection or partial or radical cystectomy at a single institution between years of 1995 to 2011.
Clinicopathologic characteristics and oncologic outcomes of patients were retrospectively analyzed, including tissue
histology re-review by genitourinary pathologists.
Results: Histologically, 9 cases (41%) were non-invasive papillary urothelial carcinoma, 13 cases (59%) were invasive
urothelial carcinoma, including three cases of small cell carcinoma. Final pathology revealed synchronous extradiverticular
urothelial carcinomas in 6 out of 9 cases (67%) of non-invasive and 2 out of 10 cases (20%) invasive intradiverticular
urothelial carcinoma, respectively. More than half of cases (13/22, 59%) showed a distinctive hypertrophic layer of
muscularis mucosae. There was no statistical difference in disease free survival or overall survival between
non-invasive and invasive tumors within approximately 3 years of follow up (mean 38 months, median
32 months). While stage T3 patients generally did poorly, oncologic outcomes for stage T1 patients were no
different than those of stage Ta.
Conclusion: Intradiverticular carcinomas are often associated with a hypertrophic layer of muscularis mucosae
that can potentially confound tumor staging. Non-invasive intradiverticular urothelial carcinomas are more likely
to have coexisting synchronous extradiverticular lesions. The absence of a muscularis propria layer may not
necessarily predispose T1 tumors to more aggressive disease.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.
eu/vs/13000_2014_222
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Intradiverticular bladder carcinoma is defined as a malig-
nant epithelial neoplasm arising within a diverticulum of
urinary bladder. The most common intradiverticular ma-
lignancy is urothelial carcinoma. Bladder diverticula are
caused by congenital or acquired defects which cause an
outpouching of bladder wall and it usually lacks the mus-
cularis propria layer (detrusor muscle) [1]. Most bladder
diverticula are small and asymptomatic. A subset of these* Correspondence: bo.xu@roswellpark.org
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unless otherwise stated.lesions, however, may be complicated with inflammation,
calculus, infection and malignancy [2,3].
Compared to that of anatomically normal urinary
bladder wall, intradiverticular urothelial lining is known
to have higher carcinoma rate with intradiverticular
bladder carcinoma occurring in approximately 10-14%
and up to 50% of all bladder diverticula [2-5]. However,
only 1.3% of urothelial carcinomas arise from vesical di-
verticula in 611 patients treated for bladder tumor [6].
Due to its rarity, intradiverticular carcinoma remains in-
frequently encountered in general practice. As result, the
histopathologic features and clinical outcomes of intradi-
verticular bladder carcinoma are not well investigated,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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erature, each including less than 40 patients [2,3,7,8].
While absence of muscularis propria layer may in theory
predispose intradiverticular tumors to a greater risk for
bladder wall infiltration and possibly spreading into adja-
cent organs, the aggressiveness of these tumors and their
clinical outcomes remain poorly characterized. In this
study, we aimed to expand current understanding of this
unique neoplasm presentation by characterizing the his-
topathologic features and clinical outcomes of 22 pa-
tients with intradiverticular bladder carcinoma.
Methods
Case selection
This study was approved by the Roswell Park Institu-
tional Review Board.
Twenty-two consecutive cases of intradiverticular car-
cinoma were identified from institutional surgical path-
ology archive spanning from 08/1995 to 12/2011 (month/
year). Patient clinical and follow-up data were abstracted
from both medical records and an institution based tumor
registry that retrospectively maintains clinical outcomes.
The diverticula and/or intradiverticular tumors were all
clinically diagnosed by preoperative cystogram, cystos-
copy, computerized tomography scan or magnetic reson-
ance imaging. Tumor grading and staging were based on
current World Health Organization (WHO) classification
and AJCC manual (7th edition). Surgical procedures per-
formed included 6 radical cystectomies (27%), 7 diverticu-
lectomies/partial cystectomies (32%) and 9 transurethral
resection (TUR) specimens (41%). Hematoxylin-eosin
slides were re-reviewed by two genitourinary specialized
pathologists (HZ and BX) for all 22 cases. In cases with
multifocal intradiverticular lesions, the one with higher
grade and higher stage was used in further analysis. For
histomorphological comparison purpose, four benign
bladder diverticular cases and 8 cases of radical cystecto-
mies treated for conventional urothelial carcinoma (not
associated with diverticulum) were randomly selected dur-
ing the same period of time.
Statistical methods
Continuous variables were reported as mean value +/−
standard deviation (SD) and/or median value. The
Kaplan-Meier method was used to estimate survival from
the date of therapeutic procedure to the end point in the
entire cohort and in the subsets of patients. All analyses
were conducted in the MedCalc statistical software with a
nominal significance level of 0.05. Date of death due to
bladder cancer was used as the endpoint in estimating the
overall survival. The endpoint in estimating disease free
survival was disease recurrence including positive malig-
nant cells in urine cytology specimens or disease progres-
sion (metastasis with or without evidence of local diseaserecurrence). The local disease recurrence included all le-
sions identified in the remaining urinary bladder after sur-
gical procedures and adjuvant therapies.
Results
Clinical features
All patients were Caucasian and all but one were male.
Patient age ranged from 39 to 85 years, with a mean of
68 years (median 70 years). Tumor sizes ranged from 0.5
to 5.5 cm, with a mean of 2.2 cm (median 1.9 cm). Loca-
tions of the intradiverticular lesions were specified in
20/22 cases (91%). The majority of tumors (15/20, 75%)
involved the lateral walls, including the left lateral (7/
20), right lateral (7/20), or bilateral (1/20). Less common
locations involved the right base (1/20), right anterior
(1/20), posterior (1/20), dome (1/20) or trigone (1/20).
The number of lesions was specified in 18/22 cases
(82%). The majority of tumors (14/18, 78%) were solitary
within a single diverticulum (Table 1). Multifocal intradi-
verticular lesions were grossly identified in four cases.
One case had two diverticula, with each diverticulum in-
volved by a solitary tumor.
Histologic features
Histologically, 9 cases (41%) were non-invasive papillary
urothelial carcinomas, 10 cases (45%) were invasive
urothelial carcinomas and 3 cases (14%) were invasive
small cell carcinomas. All invasive tumors and 6/9 (67%)
non-invasive ones were high grade carcinomas. Six out
of 10 invasive urothelial carcinomas had coexisting
minor histological growth patterns (2 micropapillary, 2
non-invasive papillary, 1 glandular plus chondroid and 1
glandular plus tubular). Two cases of small cell carcinoma
had coexisting high grade invasive urothelial carcinoma;
one with additional glandular differentiation. Urothelial
carcinoma in situ (CIS) was present in 3/10 (30%) invasive
urothelial carcinoma and all 3 small cell carcinoma cases.
Of 13 invasive carcinomas, including either urothelial car-
cinoma or small cell carcinoma, 8 cases were T1 and 5
cases were T3 tumors (Table 1). Synchronous extradiverti-
cular urothelial carcinomas were observed in 6 out of 9
cases (67%) of non-invasive and 2 out of 10 cases (20%) in-
vasive intradiverticular urothelial carcinoma, respectively.
More than half of the cases (13/22, 59%) showed a dis-
tinctive hypertrophic muscularis mucosae. Among them,
8 cases were invasive urothelial carcinomas, 4 were non-
invasive urothelial carcinomas, and 1 was the small cell
carcinoma with coexisting high grade urothelial carcinoma
component. In contrast to normal appearance of muscu-
laris mucosae which was often found in loose subepithelial
connective tissue (lamina propria) and retained some dis-
tance from the overlying urothelium, the hypertrophic
muscularis mucosae was usually located immediately be-
neath the urothelial mucosae and often above vasculatures






Sex (No.)/Age, mean (range) 68 (39–85)
Male (n = 21)
Female (n = 1)
Race, No. (%)
Caucasian 22 (100%)













Diagnosis, No. (%)/Specimen type, No.
Non-invasive papillary urothelial carcinoma 9 (41%)
TUR only 7
Diverticulectomy 2












No. or n indicates the number of cases.
TUR indicates transurethral resection of bladder tumour.
*The tumor staging is based on the current World Health Organization (WHO)
classification/AJCC manual 7th edition.
@ 9 cases of pTa (based on the intradiverticular pathological staging), 2 out of
9 these cases were pT1 in their extradiverticular lesions. Survival statistics was
based on the higher staging regardless of the tumor locations.
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laris mucosae was mostly disorganized (multiple polarities)
in a continuous pattern, as oppose to normal muscularismucosae that is often organized (single polarity) with
discontinuous pattern. In partial and radical cystectomy
specimens, the hypertrophic muscularis mucosae were fre-
quently seen starting from the intradiverticular neck re-
gion. In addition, prominent vessels or even hypertrophic
vessel walls were often present within the diverticula. The
bundles of hypertrophic muscularis mucosae were some-
times randomly mixed with the infiltrating tumor cells. Oc-
casionally, isolated small bundles of muscularis propria
were found in the diverticular neck region.
Hypertrophic muscularis mucosae are not unique to
intradiverticular malignancy as it can be also found in
bladder diverticula with benign conditions or prostatic
disease. Of randomly selected 4 benign bladder divertic-
ula and 8 radical cystectomy Specimens without diver-
ticulum (Figure 2), hypertrophic muscularis mucosae
was identified in one out of 4 benign bladder diverticula
and 2 out of 8 radical cystectomy specimens treated for
conventional (not associated with diverticulum) urinary
bladder carcinoma.
Clinical follow-up
Clinical follow-up was available for all 22 patients, with a
mean follow-up of 38 months (range 1–135 months, me-
dian 32 months). Of the 9 patients with non-invasive pap-
illary urothelial carcinoma, two were free of disease at last
follow up; two died of other disease with no evidence of
recurrence; five developed recurrences within the bladder.
Recurrent disease was treated with transurethral resection
(TUR) (N = 3) or diverticulectomy (N = 2). Among 3
TUR treated patients, two died of disease with one experi-
enced grade progression and developed metastases to the
lung and liver, and the other one developed lymph node
metastasis. Of two patients treated with diverticulectomy,
one recurred after 33 months and the other one remained
disease-free after 40 months.
In 10 patients with infiltrating urothelial carcinoma, all
but one were treated with partial (N = 3) or radical cyst-
ectomy (N = 6), while the remaining patient underwent
conservative TUR management. Half of these 10 patients
were free of disease till the last follow-up which was a
median of 51 months; three died of disease at 17, 26 and
41 months after surgery with distant metastases; one re-
curred with local disease after 18 months but was alive
20 months after surgery; one developed lung metastasis
after one month but was alive 10 months after surgery.
Among 3 patients with small cell carcinoma, two of
them recurred shortly after surgical procedures at 1 and
4 months. One died of disease with disseminated metas-
tases 13 months after surgery.
Disease free survival time was similar between patients
with non-invasive and infiltrating urothelial carcinoma
(median disease free survival time 31 versus 29 months,












Extradiverticular Diverticular neck Intradiverticular
MP
Figure 1 Representative sections from a radical cystectomy specimen with intradiverticular urothelial carcinoma. The H&E slides are
from extradiverticular (A and B), diverticular neck (C and D) or intradiverticular (E & F) regions with low (A, C, E – 40X) or higher magnifications
(B, D, F – 200X). MM: Muscularis mucosa; MP: Muscularis propria.
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24 months, p = 0.4156) (Figure 3B), but significantly differ-
ent among patients with pT3 tumour (median disease free
survival time 1 month) compared to those with pTa (p =
0.0112, Hazard ratio 3.3897, 95% CI 0.7679 – 14.9638) or
pT1 (p = 0.0047, Hazard ratio 4.9579, 95% CI 0.9721 –
25.2819) (Figure 3B). The differences of overall sur-
vival time, however, were not statistically significant




Figure 2 Representative sections of hypertrophic muscularis mucosae
with completely denuded urothelium (upper tissue edge), showing hypert
conventional (lesion not arising from diverticula) neoplastic bladder wall of
muscularis mucosae. Low (A, C – 40X) or higher magnifications (B, D – 100among different subgroups of carcinoma within the
follow-up period (Figure 3C and D).
Discussion
The earliest literature describing a diverticulum of the
urinary bladder dates back to a century ago [1,9], docu-
menting discovery of the unique anatomic and histological
features of the congenital (muscularis propria present) or
acquired (muscularis propria absent) diverticulum. There. The H&E sections from bladder wall of a benign bladder diverticulum
rophic muscularis mucosae (A and B). C and D are from the












































































Figure 3 Comparison of disease free survival (A and B) and overall survival (C and D) among patients with different histological types
(A and C) or with different pathologic stages (B and D) of intradiverticular bladder carcinomas. In Figure 3B, Recurrence probability was
compared between T3 and Ta (p = 0.0112), or T1 (p = 0047). Recurrence probability was not statistically different between Ta and T1 (p = 0.4156).
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management, pathological staging and prognostic features
of bladder carcinoma arising in this unusual setting due to
scarcity of sufficient cases and focused investigation. Our
study supports findings that lamina propria layer within
the diverticulum commonly features hypertrophic muscu-
laris mucosae, with the normally thin and wispy smooth
muscle fiber layer taking on an unusually haphazard ar-
rangement and irregular shape [4,10-12].
Accurate recognition of hypertrophic muscularis mu-
cosae has key clinical implications. Since the hypertrophic
muscularis mucosae may morphologically resemble mus-
cularis propria, it is not uncommon to lead to a misinter-
pretation of pathologic staging of the tumour particularly
in TUR specimens, resulting in inappropriate staging [13].
To date, there are no clear histological criteria to define
the hypertrophic muscularis mucosae. In recent years, ex-
tensive efforts have aimed to employ smoothelin as an im-
munohistochemical marker to differentiate muscularis
propria from the muscularis mucosae. Although smoothe-
lin stain appears to be somewhat useful to distinguishmuscularis mucosa from muscularis propria, the intensity
of smoothelin expression in the muscularis propria appears
to be similar as compared to that in the hypertrophic mus-
cularis mucosae. It is reported that hypertrophic muscu-
laris mucosae show 2+ smoothelin staining in one third of
the specimens tested [11]. Therefore, it is our opinion that
careful histomorphologic examination is still the most reli-
able method to distinguish hypertrophic muscularis mu-
cosae from muscularis propria.
In our current study, all specimens with full thickness
bladder wall resection did not show definite intact mus-
cularis propria within diverticula, presumably reflecting
acquired rather than congenital diverticula. A few radical
cystectomy specimens showed irregular layers of muscu-
laris propria adjacent to the diverticular neck region
(Figure 1C). In contrast, hypertrophic muscularis mu-
cosae was identified in more than half cases (13/22,
59%). We summarize the following histological features
to aid in identification of hypertrophic muscularis mu-
cosae: 1) hypertrophic muscularis mucosae is usually lo-
cated immediately beneath the urothelial mucosae above
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cularis mucosae is usually disorganized (multiple polar-
ities or non-linear) but shows more continuous pattern
compared to the normal muscularis mucosae; and 3) the
muscularis mucosae often becomes hypertrophic starting
from the intradiverticular neck region.
The cause of hypertrophic mucosae is most likely
multifactorial. Weakened urinary bladder wall in diver-
ticulum due to lack of the muscularis propria is likely
the main mechanism that causes hypertrophic muscu-
laris mucosae, which can therefore compensate for the
lost strength of the bladder wall in a diverticulum. In
addition, the contraction of bladder will cause stretching
of the muscularis mucosae in the diverticulum and Frank-
Starling’ law may come into play for output of urine from
this region. Ultimately, this area develops hypertrophied
muscularis mucosae over time. The prominent vessels
and/or hypertrophic vessel walls within the diverticula as
demonstrated in current study may be additional compen-
satory mechanisms involved. Other mechanisms under-
lying hypertrophic muscularis mucosae may include
urinary outflow obstruction, local chronic irritation and
others. At molecular level, growth factors have been dem-
onstrated to be able to stimulate muscle particularly
smooth muscle proliferation predominately through acti-
vation of mitogen-associated protein kinases [14-16].
These growth factors, especially TGF- β, are frequently
shown to be expressed at high levels in and promote the
progression of urothelial carcinoma [17]. Therefore, it is
reasonable to speculate that these growth factors can be
synchronously involved in hypertrophic process of the
muscularis mucosae. In our study, cases with hypertrophic
muscularis mucosae are found in 8 out of 10 infiltrating
urothelial carcinomas (80%), 4 out of 9 non-invasive car-
cinomas (44%) and 1 out of 3 small cell carcinomas (33%).
Although the hypertrophic muscularis mucosae is not spe-
cific to any particular pathophysiolocal conditions, one
should realize that it is very likely present in intradiverti-
cular invasive urothelial carcinoma specimens, with much
higher frequency than other bladder lesions - either be-
nign or malignant. Recognizing this histological landmark
is critical in surgical pathology practice, particularly in the
setting of intradiverticular urothelial carcinoma.
Based on current practice, intradiverticular urothelial
carcinoma is often staged and treated aggressively as it is
thought to be more likely to disseminate [8,18,19]. How-
ever, clinical outcome in patients with carcinoma arising
in bladder diverticula is uncertain due to insufficient
case number and short follow-up time in the published
literature. The current study was limited to predomin-
antly Ta and T1 patients, and follow-up data was avail-
able on all 22 patients with on average 3 years. Given
most recurrences occur within one year of various treat-
ment modalities, this follow up length allows for certaininferences to be made. Total 10 patients were classified as
T1 in clinical follow-up, including 8 with T1 tumour
within diverticula and 2 with Ta tumour within diverticula
but T1 extradiverticular lesion. Total 9 patients were clas-
sified having Ta tumors. Our current study shows that pa-
tients with Ta and T1 tumors share similar chance for
disease recurrence, which is probably due to that those T1
patients benefit from more aggressive managements in-
cluding radical cystectomy performed in half of these
patients (Table 1). However, patients with T3 disease in
this study had poor disease free outcomes in comparison
with those with T1 disease as expected, despite common
bladder-sparing approaches as definitive treatment for
both groups. While our conclusions are limited by sample
size, follow up interval, and absence of T2 disease for
comparison, these findings suggest the missing muscularis
propria layer may not necessarily confer more disease
recurrence behavior to T1 lesions. Whether the hyper-
trophic muscularis mucosae play a role in bladder cancer
with local invasion remains to be investigated. Further-
more, some of our cases actually had multiple resections
because of recurrence or had additional postsurgical man-
agements, such as BCG therapy. It is not feasible to fur-
ther subgroup these cases again based on small number of
cases. Collaborative multicentric and case–control stud-
ies/meta-analyses are now needed to improve understand-
ing of the histopathologic features, biological significances
and clinical outcome of intradiverticular urothelial carcin-
oma in comparison with that of conventional urothelial
carcinoma.
Conclusion
In this retrospective study, we confirmed previous obser-
vation that intradiverticular carcinomas are often associ-
ated with a hypertrophic layer of muscularis mucosae that
can potentially confound tumor staging. Non-invasive
intradiverticular urothelial carcinomas are more likely to
have coexisting synchronous extradiverticular lesions. The
absence of a muscularis propria layer may not necessarily
predispose T1 tumors to more aggressive disease.
Competing interests
The authors declare that they have no competing interests.
Authors’ contribution
HZ carried out histologic slides/clinical information review, statistical analyses
and drafting the manuscript. SG, EK and KG were responsible to obtain
clinical information and review, as well as help to edit the manuscripts. GA
helped case selection and histology review. BX oversees all aspects of this
study, from design, case selection, histology review and finalizing the
manuscript. All authors read and approved the final manuscript.
Author details
1Department of Pathology and Laboratory Medicine, Roswell Park Cancer
Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. 2Department of
Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY
14263, USA. 3Department of Urology, Roswell Park Cancer Institute, Elm and
Carlton Streets, Buffalo, NY 14263, USA. 4Current address: Department of
Zhong et al. Diagnostic Pathology 2014, 9:222 Page 7 of 7
http://www.diagnosticpathology.org/content/9/1/222Pathology and Laboratory Medicine, Robert Wood Johnson Medical School,
UMDNJ, One Robert Wood Johnson Place - MEB 212, New Brunswick, NJ
08901, USA.
Received: 23 September 2014 Accepted: 10 November 2014
References
1. Scholl AJ: Xanthoma and carcinoma in a diverticulum of the urinary
bladder. Trans Am Assoc Genitourin Surg 1945, 37:67–71.
2. Tamas EF, Stephenson AJ, Campbell SC, Montague DK, Trusty DC, Hansel
DE: Histopathologic features and clinical outcomes in 71 cases of
bladder diverticula. Arch Pathol Lab Med 2009, 133:791–796.
3. Kong MX, Zhao X, Kheterpal E, Lee P, Taneja S, Lepor H, Melamed J, Deng
FM: Histopathologic and clinical features of vesical diverticula.
Urology 2013, 82:142–147.
4. Melekos MD, Asbach HW, Barbalias GA: Vesical diverticula: etiology,
diagnosis, tumorigenesis, and treatment. Analysis of 74 cases.
Urology 1987, 30(5):453–457.
5. Prakash, Rajini T, Kumar Bhardwaj A, V J, Kalyani Rao P, Singh G: Urinary
bladder diverticulum and its association with malignancy: an anatomical
study on cadavers. Rom J Morphol Embryol 2010, 51(3):543–545.
6. Baniel J, Vishna T: Primary transitional cell carcinoma in vesical
diverticula. Urology 1997, 50:697–699.
7. Golijanin D, Yossepowitch O, Beck SD, Sogani P, Dalbagni G: Carcinoma in
a bladder diverticulum: presentation and treatment outcome. J Urol
2003, 170:1761–1764.
8. Idrees MT, Alxander RE, Kum JB, Cheng L: The spectrum of histopathologic
findings in vesical diverticulum: implications for pathogenesis and
staging. Hum Pathol 2013, 44:1223–1232.
9. Martin SP: Dumb-bell stone in diverticulum of urinary bladder. Ann Surg
1918, 67(1):94–95.
10. Vakar-Lopez F, Shen SS, Zhang S, Tamboli P, Ayala AG, Ro JY: Muscularis
mucosae of the urinary bladder revisited with emphasis on its
hyperplastic patterns: a study of a large series of cystectomy specimens.
Ann Diag Pathol 2007, 11:395–401.
11. Hansel DE, Paner GP, Nese N, Amin MB: Limited smoothelin expression
within the muscularis mucosae: validation in bladder diverticula.
Hum Pathol 2011, 42:1770–1776.
12. Ro JY, Ayala AG, El-Naggar A: Muscularis mucosa of urinary bladder:
importance for staging and treatment. Am J Surg Pathol 1987, 11:668–673.
13. Miyamoto H, Epstein JI: Transurethral resection specimens of the bladder:
outcome of invasive urothelial cancer involving muscle bundles
indeterminate between muscularis mucosae and muscularis propria.
Urology 2010, 76(3):600–602.
14. Suwanabol PA, Seedial SM, Shi X, Zhang F, Yamanouchi D, Roenneburg D,
Liu B, Kent KC: Transforming growth factor-β increases vascular smooth
muscle cell proliferation through the Smad3 and ERK MAPK pathways.
J Vasc Surg 2012, 56(2):446–454.
15. Li J, Huang SL, Guo ZG: Platelet-derived growth factor stimulated vascular
smooth muscle cell proliferation and its molecular mechanism.
Acta Pharmacol Sin 2000, 21(4):340–344.
16. Jump SS, Childs TE, Zwetsloot KA, Booth FW, Lees SJ: Fibroblast growth
factor 2-stimulated proliferation is lower in muscle precursor cells from
old rats. Exp Physiol 2009, 94(6):739–748.
17. Shariat SF, Kim JH, Andrews B, Kim JH, Andrews B, Kattan MW, Wheeler TM,
Kim IY, Lerner SP, Slawin KM: Preoperative plasma levels of transforming
growth factor β1 strongly predict clinical outcome in patients with
bladder carcinoma. Cancer 2001, 92(12):2985–2992.
18. Redman JF, McGinnis TB, Bissada NK: Management of neoplasms in vesical
diverticula. Urology 1976, 7(5):492–494.
19. Walker NF, Gan C, Olsburgh J, Khan MS: Diagnosis and management of
intradiverticular bladder tumors. Nat Rev Urol 2014, 11(7):383–390.
doi:10.1186/s13000-014-0222-8
Cite this article as: Zhong et al.: Clinicopathologic characterization of
intradiverticular carcinoma of urinary bladder - a study of 22 cases from
a single cancer center. Diagnostic Pathology 2014 9:222.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
